Page 4 - ஜான்ஸ் ஹாப்கின்ஸ் தொழில்நுட்பம் முயற்சிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bayer extends research agreement with Hopkins through 2024 The pharmaceuticals and life sciences company will continue its partnership with Johns Hopkins to provide funding to researchers in the Wilmer Eye Institute Credit: Wikimedia Commons May 6, 2021 The Johns Hopkins University and Bayer AG have extended their strategic research alliance in ophthalmology through the end of 2024. The agreement will provide multimillion-dollar funding for researchers at the Johns Hopkins Wilmer Eye Institute to pursue treatments for a variety of eye diseases and ailments while benefitting from the expertise of Bayer scientists about potential drug candidates. A drug candidate from one of the collaboration s programs has advanced to a phase II clinical trial and another program is licensed to a startup company. Researchers on both sides hope to translate the joint research into improved vision by moving innovative treatments from labs to patients eyes.

Janice linNeilm bresslerBydanny jacobspublishedPeterj mcdonnellJohns hopkinsJohns hopkins universityBayer agSchool of medicineJohns hopkins technology venturesJohns hopkins university school of medicineWilmer eye instituteCommercialization academyJohns hopkins wilmer eye instituteAssociation for researchWilmer eyeJohns hopkins technology